OMERS Administration Corp’s TScan Therapeutics TCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-14,200
Closed -$113K 1207
2024
Q1
$113K Buy
+14,200
New +$113K ﹤0.01% 315